최은지 조교수
#골수이식#골수구성백혈병#골수형성이상증후군#재생불량성빈혈
|
학력
2016 .03 ~ 2020 .02울산대학교 의학 박사
2013 .03 ~ 2015 .02울산대학교 의학 석사
2004 .02 ~ 2010 .02경희대학교 의학 학사
2013 .03 ~ 2015 .02울산대학교 의학 석사
2004 .02 ~ 2010 .02경희대학교 의학 학사
경력
2020 .03 ~ 현재서울아산병원 혈액내과 조교수
2017 .03 ~ 2020 .02서울아산병원 혈액내과 임상전임강사
2015 .03 ~ 2017 .02서울아산병원 혈액내과 임상강사(전임의, 펠로우)
2011 .03 ~ 2015 .02서울아산병원 내과 전공의(레지던트)
2010 .03 ~ 2011 .02서울아산병원 수련의(인턴)
2017 .03 ~ 2020 .02서울아산병원 혈액내과 임상전임강사
2015 .03 ~ 2017 .02서울아산병원 혈액내과 임상강사(전임의, 펠로우)
2011 .03 ~ 2015 .02서울아산병원 내과 전공의(레지던트)
2010 .03 ~ 2011 .02서울아산병원 수련의(인턴)
논문
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic
Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity.
Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression.
Superficial Esophageal Neoplasms Overlying Leiomyomas Removed by Endoscopic Submucosal Dissection: Case Reports and Review of the Literature.
Diffuse Large B-Cell Lymphoma with Involvement of the Breast and Testis in a Male Patient.
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic
Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity.
Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression.
Superficial Esophageal Neoplasms Overlying Leiomyomas Removed by Endoscopic Submucosal Dissection: Case Reports and Review of the Literature.
Diffuse Large B-Cell Lymphoma with Involvement of the Breast and Testis in a Male Patient.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Anti-leukemic effects of vosaroxin, an anti-cancer quinolone derivative, on hypomethylating agent resistant cells
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
영상자료
영상자료 내용이 없습니다.
발표자료
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Donor-Derived Natural Killer Cell Infusion after HLA-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants
Clinical Outcomes of HLA-haploidentical Hematopoietic Stem Cell Transplantation of Acute Myeloid Leukemia in Complete Remission
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Expression of JL1 Antigen in Acute Leukemia or Myelodysplastic Syndrome
Efficacy and safety of dose attenuated CHOP chemotherapy for peripheral T-cell lymphoma (PTCL) in elderly patients
Alloegeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia In Remission ? a
Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors
Donor-Derived Natural Killer Cell Infusion after HLA-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants
Clinical Outcomes of HLA-haploidentical Hematopoietic Stem Cell Transplantation of Acute Myeloid Leukemia in Complete Remission
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Expression of JL1 Antigen in Acute Leukemia or Myelodysplastic Syndrome
Efficacy and safety of dose attenuated CHOP chemotherapy for peripheral T-cell lymphoma (PTCL) in elderly patients
Alloegeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia In Remission ? a
Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors